Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1537141 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL24179 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1685498 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4169271 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4454478 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL5859562 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6350676 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7920203 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3793709 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL2933964 | 1.00 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6995293-B2 | Method for the production of aldehydes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2006-02-07 | — | — | US | disclosed |
| US-20050085671-A1 | Method for the production of aldehydes | DRACHENFELSSEE 521. VV GMBH (TO BE RENAMED OXEA DEUTSCHLAND GMBH) (DE) | 2005-04-21 | — | — | US | disclosed |
| EP-1400504-A1 | Process for the preparation of aldehydes | Celanese Chemicals Europe GmbH (DE) | 2004-03-24 | — | — | EP | disclosed |
| US-6703507-B2 | NONAQUEOUS LIQUID COMPRISING THE AMMONIUM SALT OF A SULFONATED OR CARBOXYLATED PHOSPHITE LIGAND; USE AS A MEDIA FOR CHEMICAL REACTIONS, INCLUDING THOSE USING TRANSITION METAL CATALYSTS | CELANESE CHEMICALS EUROPE GMBH (DE) | 2004-03-09 | — | — | US | disclosed |
| EP-1177163-B1 | METHOD FOR PRODUCING ALDEHYDES | CELANESE CHEM EUROPE GMBH (DE) | 2004-02-04 | — | — | EP | disclosed |
| US-20020161261-A1 | Nonaqueous liquid comprising the ammonium salt of a sulfonated or carboxylated phosphite ligand; use as a media for chemical reactions, including those using transition metal catalysts | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-10-31 | — | — | US | disclosed |
| US-6472565-B1 | Method for producing aldehydes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-10-29 | — | — | US | disclosed |
| EP-1177199-B1 | IONIC LIQUIDS AND PRODUCTION AND USE THEREOF | CELANESE CHEM EUROPE GMBH (DE) | 2002-09-11 | — | — | EP | disclosed |
| US-6114272-A | CATALYST FOR PREPARING ALDEHYDES BY HYDROFORMYLATION OF OLEFINS OR OLEFINICALLY UNSATURATED COMPOUNDS | CELANESE GMBH (DE) | 2000-09-05 | — | — | US | disclosed |
| US-6103908-A | HYDROFORMYLATION CATALYSTS; SIMPLIFICATION, EFFICIENCY | CELANESE GMBH (DE) | 2000-08-15 | — | — | US | disclosed |
| US-6025529-A | CATALYTIC HYDROFORMYLATION OF OLEFIN UNSATURATED COMPOUNDS IN THE PRESENCE OF A MIXTURE HAVING A RHODIUM COMPOUND AND A NONAQUEOUS IONIC LIGAND QUATERNARY AMMONIUM AND/OR PHOSPHONIUM CATION AND SULFONATED TRIARYLPHOSPHINE ANION | CELANESE GMBH (DE) | 2000-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161261-A1 | Nonaqueous liquid comprising the ammonium salt of a sulfonated or carboxylated phosphite ligand; use as a media for chemical reactions, including those using transition metal catalysts | SLC11A2, NSUN2, SSB | DNM1 441/4885TSHR 3400/4885MEN1 3041/4885 |
| US-20050085671-A1 | Method for the production of aldehydes | ACSL3, ACSL5, TST | DNM1 3638/4885TSHR 3705/4885MEN1 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.